Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiff Advisory is a boutique strategic and investment banking advisory firm focused primarily on healthcare and life sciences clients. The firm provides sell-side and buy-side M&A, licensing and partnering, capital formation, valuation, financial modeling, and fractional executive advisory services for founder-led and lower-middle-market companies. Its sector coverage spans biotechnology, diagnostics, medical devices, digital health, CDMO/CRO services, and broader healthcare services. Cardiff Advisory appears to operate as a services business rather than a drug developer, so it does not maintain a proprietary therapeutic pipeline. The firm is led by David H. Crean and is based in the San Diego area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiff Advisory.